Jazz Pharma’s Cannabinoid Spray Fails MS Trial Endpoint
An Irish biopharmaceutical company has announced top-line results from its Phase 3 trial on a cannabinoid-based multiple sclerosis (MS) treatment. …
July 1, 2022/
Cannabis, CBD, Industry, Medical, medical cannabis, Research, Science and medicine, study/